BioSpace News Archive

Business

Accelerate Diagnostics Reports First Quarter 2022 Financial Results

Accelerate Diagnostics, Inc. announced financial results for the first quarter for the period ended March 31, 2022.

May 16, 2022
·
10 min read
Business

Biostage Reports Q1 2022 Financial Results and Corporate Highlights

Biostage, Inc. announced its financial results for the three months ended March 31, 2022, and highlighted recent events.

May 16, 2022
·
9 min read
Biotech Bay

Eiger BioPharmaceuticals to Present at H.C. Wainwright Global Investment Conference

Eiger BioPharmaceuticals, Inc. announced that David Cory, President and CEO, will present a company overview at the H.C. Wainwright Global Investment Conference on Tuesday, May 24, 2022 at 10:30 AM ET in Miami, Florida. Eiger will also host one-on-one meetings with investors at the conference.

May 16, 2022
·
1 min read
Business

Aridis Pharmaceuticals Announces First Quarter 2022 Financial Results and Business Update

Aridis Pharmaceuticals, Inc. reported financial and corporate results for its first quarter ended March 31, 2022.

May 16, 2022
·
14 min read
Business

Pear Therapeutics Reports First Quarter 2022 Financial Results

Pear Therapeutics, Inc., the leader in developing and commercializing software-based medicines called prescription digital therapeutics, reported financial results for its first quarter ended March 31, 2022.

May 16, 2022
·
12 min read
BioCapital

Senseonics to Participate in the H.C. Wainwright Global Investment Conference - May 16, 2022

Senseonics Holdings, Inc., a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring systems for people with diabetes, announced plans to participate in the upcoming hybrid H.C. Wainwright Global Investment Conference.

May 16, 2022
·
1 min read
Pharm Country

AngioDynamics to Present at the UBS Global Healthcare Conference - May 16, 2022

AngioDynamics, Inc. announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the UBS Global Healthcare Conference at 4:15 p.m. ET on Monday, May 23, 2022.

May 16, 2022
·
1 min read
Business

Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results

Dermata Therapeutics, Inc., a clinical-stage biotechnology company focusing on the treatment of medical and aesthetic skin conditions, highlighted recent corporate progress and reported financial results for the quarter ended March 31, 2022.

May 16, 2022
·
7 min read
Lone Star Bio

Lumos Pharma to Participate in Upcoming Investor Conferences - May 16, 2022

Lumos Pharma, Inc., a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced that the Company will participate in the following upcoming investors conferences:

May 16, 2022
·
1 min read
Business

Nkarta Appoints David R. Shook, MD, as Vice President, Clinical Development

Nkarta, Inc., a clinical-stage biopharmaceutical company developing engineered natural killer cell therapies to treat cancer, announced the appointment of David R. Shook, MD, as Vice President, Clinical Development.

May 16, 2022
·
7 min read